ACTINOGEN LIMITED (ACW)

Commercialisation of bioactive compounds

On this page you will find:

Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
ACW	0.019	46.15%	0.012	0.019	0.019	0.019	0.019	70,000

ACTINOGEN LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	ACW
Securities	ASX Code, Security Description ------------------------------ ACW, Ordinary Fully Paid ACWOA, Option Expiring 30-sep-2015
Official Listing Date	16 October, 2007
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.actinogen.com.au
Registered Office Address	Level 7, 231 Adelaide Terrace, PERTH, WA, AUSTRALIA, 6000
Head Office Telephone	+61 8 9225 4815
Head Office Fax	+61 8 9225 6474
Share Registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED LEVEL 2, RESERVE BANK BUILDING, 45 ST GEORGES TERRACE, PERTH, WA, AUSTRALIA, 6000
Share Registry Telephone	1300 787 272

Directors / Senior Management
Dr Zhukov Pervan (Executive Chairman) Dr David Keast (Director) Dr Alan Morton (Director) Mr David Zohar (Executive Director) Mr Simon Christopher England (Non Exec. Director)

Company Secretary	Ms Shoshanna Zohar
Principal Activities	Commercialisation of bioactive compounds

ACTINOGEN LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
10/05/2013		Response to ASX Appendix 4C query	4	PDF
30/04/2013		Appendix 4C - quarterly	5	PDF
10/04/2013		Change of Director's Interest Notice	2	PDF
03/04/2013		Change in substantial holding	3	PDF
03/04/2013		Change of Director's Interest Notice	2	PDF
27/03/2013		Independent trials being conducted on Plant Growth Hormones	1	PDF
28/02/2013		Appendix 4D and Half Year Accounts	18	PDF
31/01/2013		Appendix 4C - quarterly	5	PDF
29/11/2012		Results of Annual General Meeting	1	PDF
28/11/2012		2012 AGM Presentation	37	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
17 May 2013	0.019	46.15%	0.019	0.019	70,000
10 May 2013	0.013	8.33%	0.013	0.013	4,000
01 May 2013	0.012	9.09%	0.012	0.012	12,000
16 Apr 2013	0.011	-52.17%	0.011	0.011	4,000
05 Apr 2013	0.023	9.52%	0.024	0.023	145,000

* Volume of shares shown represents only those shares traded on ASX.

ACTINOGEN LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security ACW. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security ACW

Warrants & Structured Products

No warrants & Structured Products are available over the security ACW

ASX CFDs

No Contracts For Differences are available over the security ACW

MyASX: Login | Sign up